Vineet Laboratories Ltd.
| BSE: 543298 | Sector: Health care |
| NSE: VINEETLAB | ISIN Code: INE505Y01010 |
| BSE 09:51 | 24 Sep | 76.90 |
0.25 (0.33%) |
OPEN
76.00 |
HIGH
76.90 |
LOW
76.00 |
| NSE 09:39 | 24 Sep | 76.30 |
-1.05 (-1.36%) |
OPEN
79.00 |
HIGH
79.00 |
LOW
74.05 |
| OPEN | 76.00 |
| PREVIOUS CLOSE | 76.65 |
| VOLUME | 225 |
| 52-Week high | 124.70 |
| 52-Week low | 44.85 |
| P/E | 39.84 |
| Mkt Cap.(Rs cr) | 71 |
| Buy Price | 76.05 |
| Buy Qty | 50.00 |
| Sell Price | 76.75 |
| Sell Qty | 6.00 |
Vineet Laboratories Ltd. (VINEETLAB) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 732.60 | -1.00 | -0.14 | 3112.91 |
| Cipla | 974.55 | 6.50 | 0.67 | 2468.28 |
| Dr Reddy's Labs | 4810.80 | 14.80 | 0.31 | 2186.40 |
| Sun Pharma.Inds. | 774.60 | 4.85 | 0.63 | 2139.70 |
| Divi's Lab. | 5207.10 | -5.75 | -0.11 | 1954.72 |
| Alkem Lab | 3983.90 | 19.70 | 0.50 | 1685.08 |
| Glenmark Pharma. | 512.40 | 0.30 | 0.06 | 1649.45 |
| Cadila Health. | 565.15 | -1.75 | -0.31 | 1476.20 |
| Lupin | 943.10 | 2.70 | 0.29 | 1258.62 |
| Alembic Pharma | 813.05 | -6.85 | -0.84 | 1175.39 |
| Ipca Labs. | 2449.45 | -26.10 | -1.05 | 1140.77 |
| Torrent Pharma. | 3102.40 | 0.20 | 0.01 | 1137.85 |
| Gland Pharma | 3915.00 | 4.90 | 0.13 | 997.01 |
| Laurus Labs | 616.35 | -5.60 | -0.90 | 956.11 |
| Abbott India | 21700.00 | 111.55 | 0.52 | 690.69 |
| Ajanta Pharma | 2175.45 | -8.35 | -0.38 | 675.64 |
| Wockhardt | 430.95 | -1.95 | -0.45 | 593.29 |
| Granules India | 328.60 | 7.15 | 2.22 | 552.78 |
| Pfizer | 5835.80 | 14.50 | 0.25 | 497.61 |
| Sanofi India | 8203.80 | 5.05 | 0.06 | 477.60 |
Quick Links for Vineet Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
